WCO-IOF 2016: Alfacalcidol (Vit D analogue) vs. cholecalciferol (Vit D) for osteoporosis

How to Cite

OrthoEvidence. WCO-IOF 2016: Alfacalcidol (Vit D analogue) vs. cholecalciferol (Vit D) for osteoporosis. ACE Report. 2016;5(5):11. Available from: https://myorthoevidence.com/AceReport/Report/8938

Study Type:Randomized Trial

OE Level Evidence:N/A

Journal Level of Evidence:N/A

The effect of alfacalcidol and plain vitamin D on osteoporosis: a randomized controlled trial

Contributing Authors: BP Shrestha J Kathabania

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Access conference website and list of abstracts.

Synopsis

80 patients with osteoporosis were randomized to receive either alfacalcidol, a vitamin D analogue, or plain vitamin D (cholecalciferol). Both treatment groups also received calcium supplementation and alendronate. The purpose of this study was to compare the effects on bone mineral density and T-score between alfacalcidol and cholecalciferol. Results demonstrated no significant differences betwee...